Roquin2 inhibits tumor angiogenesis by selectively destabilizing proangiogenic gene transcripts, including ENG, EDN1, VEGFB, and PDGFC. Roquin2 expression was decreased in breast tumor tissues and cells. The gene discussed is VEGFB; the disease is breast neoplasm.